ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.295,98
-0,59%
S&P 500
6.021,63
0,57%
Dow Jones
44.860,31
0,28%
Euro vs US Dollar
1,04788
-0,12%
Bitcoin
92.650,00
0,74%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Boundless Bio Inc (BOLD)

  7. Boundless Bio Inc (BOLD) News

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BOLD
DatumZeitQuelleÜberschriftSymbolFirma
25/11/202413h00GlobeNewswire Inc.Boundless Bio to Participate in the Piper Sandler Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
07/11/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
07/11/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
07/11/202422h01GlobeNewswire Inc.Boundless Bio Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:BOLDBoundless Bio Inc
05/11/202413h00GlobeNewswire Inc.Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
15/10/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
14/10/202414h00GlobeNewswire Inc.Boundless Bio Announces Departure of Chief Financial OfficerNASDAQ:BOLDBoundless Bio Inc
11/09/202413h00GlobeNewswire Inc.Boundless Bio to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
21/08/202401h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BOLDBoundless Bio Inc
20/08/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
12/08/202422h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
12/08/202422h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
12/08/202422h01GlobeNewswire Inc.Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial ResultsNASDAQ:BOLDBoundless Bio Inc
05/06/202413h00Business WireBoundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
13/05/202413h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
13/05/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
13/05/202413h00Business WireBoundless Bio Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:BOLDBoundless Bio Inc
06/05/202414h00Business WireBoundless Bio to Present at the Citizens JMP Life Sciences Conference 2024NASDAQ:BOLDBoundless Bio Inc
11/04/202414h00Business WireBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene AmplificationsNASDAQ:BOLDBoundless Bio Inc
08/04/202414h00Business WireBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024NASDAQ:BOLDBoundless Bio Inc
14/02/202023h23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
14/02/202022h35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
14/02/202022h15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
11/02/202022h41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
05/02/202017h27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
27/01/202015h38Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:BOLDBoundless Bio Inc
21/01/202012h00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
21/01/202012h00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
04/12/201901h13PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.NASDAQ:BOLDBoundless Bio Inc
03/12/201900h01Business WireAstellas Enters into Definitive Agreement to Acquire Audentes TherapeuticsNASDAQ:BOLDBoundless Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BOLD

Kürzlich von Ihnen besucht

USOTC
BCCEF
Bactech Environmental (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€